What is C3is Inc. (CISS)'s fair-value range?

EvidInvest reads C3is Inc. (CISS)'s market price back into the assumptions behind it — the implied P/E, growth rate and cash yield — using its latest filed financials, then lets you set your own. See the full DCF, Graham number, EPV and multiple-based methods at https://evidinvest.com/valuation/CISS.

How is C3is Inc. (CISS)'s fair value calculated?

C3is Inc. (CISS)'s fair value is computed with several independent methods — a discounted cash flow (DCF) model, the Graham number, earnings power value (EPV), and valuation multiples such as PE and EV/EBITDA — using data from SEC filings. P/B is optional for non-financial companies and included in the preset range for financial sectors.

Which filing are C3is Inc. (CISS)'s valuation inputs based on?

Inputs come from the FY2025 annual report filed 2026-04-22 (accession 0001193125-26-170448). Source: https://www.sec.gov/Archives/edgar/data/1951067/000119312526170448/

Fair value · C3is Inc. (CISS) · updated 2026-10-29 · from annual report FY2025

C3is trades at $0.50. That price implies a P/E of 0.0×.

Name: C3is Inc. (CISS) valuation inputs and fair-value methods
Creator: EvidInvest
License: https://evidinvest.com/subscription-terms

Cboe · delayed 15 min · as of 20:05 ET

Are those assumptions reasonable? Use CISS’s filed growth history and the AI chat to decide, then set your own inputs below — the range you build is yours.

What the price implies

P/E: 0.0×

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings. This price: Cboe · delayed 15 min · as of 20:05 ET.

Set your own assumptions ↓See how each method got its number Check another stock

Inputs come from the FY2025 annual report filed 2026-04-22 (accession 0001193125-26-170448); set your own on the sliders below. Research, not investment advice.

The filing behind these numbers

C3is Inc.

Revenue: $34.8M
Diluted EPS: $159.20
Free cash flow: $3.8M; operating cash flow − capital expenditure
Diluted shares: 8751; weighted average

annual report FY2025 · fiscal year ended 2025-12-31 · filed 2026-04-22 · accession 0001193125-26-170448

Open this filing on sec.gov

Valuation tool: build your own CISS range

Fair Value Summary

Daily Price — CISS

$0.49 -100.0% (1Y)

Your range0 of 7 methods

At least two methods need a usable value to draw a range with these inputs.

Range with preset inputs

No preset range for this company yet.

The two ranges are identical because every input sits on a preset.

We don’t tell you what CISS is worth. Every tab OPENS on what today’s price implies for that method’s key assumption; you decide whether that assumption is reasonable — the growth matrix has CISS’s filed history and the AI chat will reason it through with you — and the range you build is yours. Our presets are filed history and reference settings, never a recommendation.

Discounted cash flow

$37012.52per share

7402404% above the $0.50 price· outside the ±300% band, left out of the range

Preset inputs — revenue-driven DCF from the latest filing

Implied by today’s price

Shares outstanding unavailable.

Not solvable from the price — Shares outstanding unavailable. Showing preset inputs.

This method has no key input to read out of the price. The others below do, and you set them yourself: the growth matrix shows what CISS has actually filed, and the AI chat will reason it through with you.

Your inputs

Free cash flow grows at your stage-1 rate, then your stage-2 rate, then a terminal rate; everything is discounted at your WACC.

Stage-1 growth5.0%

Yearly free-cash-flow growth for the first stage. Starts below zero so a shrinking-cash-flow case — and the rate today’s price implies — can be set.

-20.0%60.0%

Stage-1 years5 yrs

How long stage-1 growth lasts.

1 yrs10 yrs

Stage-2 growth2.5%

Slower growth after stage 1, before the terminal phase.

-20.0%30.0%

Stage-2 years5 yrs

0 yrs10 yrs

Terminal growth2.5%

Growth forever after the two stages. Above ~3% is rarely justified.

0.0%5.0%

Discount rate (WACC)12.13%

The return you require. Default is the WACC EvidInvest computed for this company. Higher discount rate, lower value.

3.00%15.00%

Net debt ($M)Debt minus cash, from the balance sheet. Subtracted from enterprise value.

Starting FCF ($M)Latest free cash flow from the filing (operating cash flow minus capex).

Shares (M)Diluted shares, from the filing.

Year by year (two-stage model, $M)

PV explicit $28M · PV terminal $20M · EV $47M · equity $48M

Year	Stage	FCF	Present value
1	Stage 1	$4M	$4M
2	Stage 1	$4M	$4M
3	Stage 1	$5M	$3M
4	Stage 1	$5M	$3M
5	Stage 1	$5M	$3M
6	Stage 2	$5M	$3M
7	Stage 2	$5M	$2M
8	Stage 2	$5M	$2M
9	Stage 2	$6M	$2M
10	Stage 2	$6M	$2M

Inputs from the filing

Free cash flow: $3.8M; latest full year
EBIT: $1.4M; latest annual
Shares: 2249
Total debt: $24751
Cash: $616640
Net debt: $-591889; debt − cash

annual report FY2025 · period ended 2025-12-31 · filed 2026-04-22 · accession 0001193125-26-170448 · sec.gov

Prefer a blank slate with reverse DCF? Open the standalone DCF / reverse DCF for CISS

Loading history...

C3is trades at $0.50. That price implies a P/E of 0.0×.

The filing behind these numbers

Valuation tool: build your own CISS range

Daily Price — CISS

Your range0 of 7 methods

Range with preset inputs

Your inputs

Year by year (two-stage model, $M)

More on CISS

Compare with peers

Explore

Valuation tool: build your own CISS range

Daily Price — CISS

Your range0 of 7 methods

Range with preset inputs

Your inputs

Year by year (two-stage model, $M)

More on CISS

Compare with peers

Explore